4610131521!
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DP26D0006
- Awardee
-
Seqirus USA Inc. UEI N6U7P2B9VHS5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 1 $10,707,567 obligated
Award facts
- Opportunity
-
- Injectable Egg-Free Influenza Vaccine 2026 Pre-Solicitation · SPE2DP25R0006 · Posted Jul 30, 2025
- Combined order value
- $10,707,567 Current and potential, with all options
- Last date to order 77% complete
- IDV ceiling 67% used
- $15,969,518.10
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Seqirus USA Inc. (UEI: N6U7P2B9VHS5) was awarded a single-award Indefinite Delivery Contract valued at $15.97 million by the Defense Logistics Agency's Medical Supply Chain, a defense-affiliated federal agency, with an award date of February 6, 2026, and ultimate completion date of February 5, 2027. This contract procures injectable egg-free influenza vaccine presented in prefilled syringes for the 2026-2027 flu season, with the specific vaccine formula to be determined by the FDA's Vaccines and Related Biological Products Advisory Committee. The vaccine must be FDA-approved for individuals 18 years and older and CDC Advisory Committee on Immunization Practices recommended. No set-aside designations were utilized in this single-award competitive procurement, reflecting Seqirus's established position as a qualified federal vaccine supplier.
The contract requires delivery to Defense Depot New Cumberland, Pennsylvania, on a phased schedule: 40 percent by August 14, 2026, 25 percent by August 28, 2026, 25 percent by September 11, 2026, and the remaining 10 percent by September 25, 2026. The procurement encompasses approximately 337,500 doses annually, with a guaranteed minimum of 75 percent of the annual estimate and a maximum of 150 percent. Seqirus, headquartered in Summit, New Jersey, is a biotechnology company with extensive experience supplying influenza vaccines to federal agencies including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, and Bureau of Prisons, maintaining multiple substantial indefinite delivery contracts totaling hundreds of millions of dollars across various federal healthcare systems and immunization programs.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Influenza virus VAC | Medical Supply Chain (DLA) | $10,707,567 |
Quick answers
Who was awarded contract SPE2DP26D0006?
SPE2DP26D0006 was awarded to Seqirus USA Inc. by Medical Supply Chain (Troop Support) on February 6, 2026.
How much is contract SPE2DP26D0006 worth?
Orders under SPE2DP26D0006 have obligated $10,707,567. SPE2DP26D0006's own ceiling is $15,969,518.
How many orders have been placed under contract SPE2DP26D0006?
1 order has been placed under SPE2DP26D0006, the latest on February 18, 2026.
Who can order from contract SPE2DP26D0006?
SPE2DP26D0006 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DP26D0006 competed?
The extent of competition for SPE2DP26D0006 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV